William Shakespeare - Net Worth and Insider Trading
William Shakespeare Net Worth
The estimated net worth of William Shakespeare is at least $2 Million dollars as of 2024-12-15. William Shakespeare is the See Remarks of Theseus Pharmaceuticals Inc and owns about 388,949 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $2 Million. Details can be seen in William Shakespeare's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Shakespeare has not made any transactions after 2021-10-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Shakespeare
William Shakespeare Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Shakespeare owns 1 companies in total, including Theseus Pharmaceuticals Inc (THRX) .
Click here to see the complete history of William Shakespeare’s form 4 insider trades.
Insider Ownership Summary of William Shakespeare
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| THRX | Theseus Pharmaceuticals Inc | 2021-10-12 | See Remarks |
William Shakespeare Latest Holdings Summary
William Shakespeare currently owns a total of 1 stock. William Shakespeare owns 388,949 shares of Theseus Pharmaceuticals Inc (THRX) as of October 12, 2021, with a value of $2 Million.
Latest Holdings of William Shakespeare
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| THRX | Theseus Pharmaceuticals Inc | 2021-10-12 | 388,949 | 4.06 | 1,579,133 |
Holding Weightings of William Shakespeare
William Shakespeare Form 4 Trading Tracker
According to the SEC Form 4 filings, William Shakespeare has made a total of 1 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 625 shares on October 12, 2021, which cost William Shakespeare around $10,000.
Insider Trading History of William Shakespeare
- 1
William Shakespeare Trading Performance
GuruFocus tracks the stock performance after each of William Shakespeare's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Shakespeare is -35.1%. GuruFocus also compares William Shakespeare's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Shakespeare within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Shakespeare's insider trading performs compared to the benchmark.
Performance of William Shakespeare
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.9 | | | | | |
| Relative Return to S&P 500(%) | 3.26 | | | | | |
William Shakespeare Ownership Network
Ownership Network List of William Shakespeare
Ownership Network Relation of William Shakespeare
William Shakespeare Owned Company Details
What does Theseus Pharmaceuticals Inc do?
Who are the key executives at Theseus Pharmaceuticals Inc?
William Shakespeare is the See Remarks of Theseus Pharmaceuticals Inc. Other key executives at Theseus Pharmaceuticals Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Orbimed Advisors Llc , and 10 percent owner Foresite Capital Fund V, L.p. .
Theseus Pharmaceuticals Inc (THRX) Insider Trades Summary
Over the past 18 months, William Shakespeare made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 700,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 479,932 shares made by Carl L Gordon , and a net purchase of 479,932 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 1,659,864 shares were bought by its insiders, resulting in a net purchase of 1,659,864 shares.
Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theseus Pharmaceuticals Inc Insider Transactions
William Shakespeare Mailing Address
Above is the net worth, insider trading, and ownership report for William Shakespeare. You might contact William Shakespeare via mailing address: 245 Main Street, 2nd Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
